The Src family kinase inhibitor, Saracatinib, induced PTEN recruitment around parasites in neural tissue and impaired recruitment of activated Akt, causing a striking reduction in parasite load and histopathology in mice with ocular and cerebral toxoplasmosis. This evidence concerns the gene AKT1 and cerebral toxoplasmosis.